MAGIC Study: Aims, Design and Methods using SystemCHANGE™ to Improve Immunosuppressive Medication Adherence in Adult Kidney Transplant Recipients

Cynthia L Russell, Shirley Moore, Donna Hathaway, An-Lin Cheng, Guoqing Chen, Kathy Goggin, Cynthia L Russell, Shirley Moore, Donna Hathaway, An-Lin Cheng, Guoqing Chen, Kathy Goggin

Abstract

Background: Among adult kidney transplant recipients, non-adherence to immunosuppressive medications is the leading predictor of poor outcomes, including rejection, kidney loss, and death. An alarming one-third of kidney transplant patients experience medication non-adherence even though the problem is preventable. Existing adherence interventions have proven marginally effective for those with acute and chronic illnesses and ineffective for adult kidney transplant recipients. Our purpose is to describe the design and methods of the MAGIC (Medication Adherence Given Individual SystemCHANGE™) trial

Methods/design: We report the design of a randomized controlled trial with an attention-control group to test an innovative 6-month SystemCHANGE™ intervention designed to enhance immunosuppressive medication adherence in adult non-adherent kidney transplant recipients from two transplant centers. Grounded in the Socio-Ecological Model, SystemCHANGE™ seeks to systematically improve medication adherence behaviors by identifying and shaping routines, involving supportive others in routines, and using medication taking feedback through small patient-led experiments to change and maintain behavior. After a 3-month screening phase of 190 eligible adult kidney transplant recipients, those who are <85 % adherent as measured by electronic monitoring, will be randomized into a 6-month SystemCHANGE™ intervention or attention-control phase, followed by a 6-month maintenance phase without intervention or attention. Differences in adherence between the two groups will be assessed at baseline, 6 months (intervention phase) and 12 months (maintenance phase). Adherence mediators (social support, systems-thinking) and moderators (ethnicity, perceived health) are examined. Patient outcomes (creatinine/blood urea nitrogen, infection, acute/chronic rejection, graft loss, death) and cost effectiveness are to be examined.

Discussion: Based on the large effect size of 1.4 found in our pilot study, intervention shows great promise for increasing adherence. Grounded in the socio-ecological model, SystemCHANGE™ seeks to systematically improve medication adherence behaviors by identifying and shaping routines, involving supportive others in routines, and using medication taking feedback through small patient-lead experiments to change and maintain behavior. Medication adherence will be measured by electronic monitoring. Medication adherence persistence will be examined by evaluating differences between the two groups at the end of the 6-and 12- month phases. Mediators and moderators of medication adherence will be examined. Patient outcomes will be compared and a cost-effectiveness analysis will be conducted.

Trial registration: ClinicalTrials.gov Registry: NCT02416479 Registered April 3, 2015.

Keywords: Adherence; Cost-effectiveness; Outcomes; Randomized controlled trial; Transplantation.

References

    1. De Geest S, Borgermans L, Gemoets H, et al. Incidence, determinants, and consequences of subclinical noncompliance with immunosuppressive therapy in renal transplant recipients. Transplantation. 1995;59(3):340–47. doi: 10.1097/00007890-199502000-00006.
    1. Hong JH, Sumrani N, Delaney V, et al. Causes of late renal allograft failure in the ciclosporin era. Nephron. 1992;62(3):272–79. doi: 10.1159/000187058.
    1. Nevins TE, Kruse L, Skeans MA, et al. The natural history of azathioprine compliance after renal transplantation. Kidney Int. 2001;60(4):1565–70. doi: 10.1046/j.1523-1755.2001.00961.x.
    1. Shoskes DA, Avelino L, Barba L, et al. Patient death or renal graft loss within 3 yr of transplantation in a county hospital: Importance of poor initial graft function. Clin Transpl. 1997;11(6):618–22.
    1. Douglas S, Blixen C, Bartucci R. Relationship between pretransplant noncompliance and posttransplant outcomes in renal transplant recipients. J Transpl Coord. 1996;6(2):53–8. doi: 10.7182/prtr.1.6.2.x11r325882657x21.
    1. Desmyttere A, Dobbels F, Cleemput I, et al. Noncompliance with immunosuppressive regimen in organ transplantation: is it worth worrying about? Acta Gastroenterol Belg. 2005;68(3):347–52.
    1. Sabate E. Adherence to long-term therapies: Evidence for action: Geneva Switzerland: World Health Organization. 2003.
    1. Dew MA, DeMartini AF, De Vito DA, et al. Rates and risk factors for nonadherence to the medical regimen after adult solid organ transplantation. Transplantation. 2007;83(7):858–73. doi: 10.1097/01.tp.0000258599.65257.a6.
    1. Gordon EJ, Gallant M, Sehgal AR, et al. Medication-taking among adult renal transplant recipients: barriers and strategies. Transpl Int. 2009;22(5):534–45. doi: 10.1111/j.1432-2277.2008.00827.x.
    1. De Geest S, Abraham I, Moons P, et al. Late acute rejection and subclinical noncompliance with cyclosporine therapy in heart transplant recipients. J Heart Lung Transplant. 1998;17(9):854–63.
    1. Butler JA, Roderick P, Mullee M, et al. Frequency and impact of nonadherence to immunosuppressants after renal transplantation: A systematic review. Transplantation. 2004;77(5):769–76. doi: 10.1097/01.TP.0000110408.83054.88.
    1. Takemoto SK, Pinskya BW, Schnitzlera MA, et al. A retrospective analysis of immunosuppression compliance, dose Reduction and discontinuation in kidney transplant recipients. Am J Transplant. 2007;7:2704–11. doi: 10.1111/j.1600-6143.2007.01966.x.
    1. Nevins TE, Robiner WN, Thomas W. Predictive patterns of early medication adherence in renal transplantation. Transplantation. 2014;98(8):878–84. doi: 10.1097/TP.0000000000000148.
    1. Peterson AM, Takiya L, Finley R. Meta-analysis of trials of interventions to improve medication adherence. Am J Health Syst Pharm. 2003;60:657–65.
    1. Roter DL, Hall JA, Merisca R, et al. Effectiveness of interventions to improve patient compliance: a meta-analysis. Med Care. 1998;36(8):1138–61. doi: 10.1097/00005650-199808000-00004.
    1. Russell CL, Conn V, Jantarakupt P. Older adult medication compliance: Integrated review of randomized controlled trials. Am J Health Behav. 2006;30:636–50. doi: 10.5993/AJHB.30.6.10.
    1. Haynes RB, Ackloo E, Sahoto N, et al. Interventions for enhancing medication adherence. Cochrane Database Syst Rev. 2008;2:CD000011.
    1. Ruppar T, Conn V, Russell CL. Medication adherence interventions for older adults: A literature review. Res Theory Nurs Pract. 2008;22(2):114–47. doi: 10.1891/0889-7182.22.2.114.
    1. De Geest S, Schaefer-Keller P, Denhaerynck K, et al. Supporting medication adherence in renal transplantation (SMART): a pilot RCT to improve adherence to immunosuppressive regimens. Clin Transplant. 2006;20:359–68. doi: 10.1111/j.1399-0012.2006.00493.x.
    1. Dew MA, Goycoolea JM, Harris RC, et al. An internet-based intervention to improve psychosocial outcomes in heart transplant recipients and family caregivers: development and evaluation. J Heart Lung Transplant. 2004;23(6):745–58. doi: 10.1016/j.healun.2003.07.002.
    1. De Bleser L, Matteson M, Dobbels F, et al. Interventions to improve medication-adherence after transplantation: a systematic review. Transpl Int. 2009;22(8):780–97. doi: 10.1111/j.1432-2277.2009.00881.x.
    1. Humpel N, Owen N, Leslie E. Environmental factors associated with adults’ participation in physical activity: A review. Am J Prev Med. 2002;22(3):188–99. doi: 10.1016/S0749-3797(01)00426-3.
    1. Webel AR, Moore SM, Hanson JE, et al. Improving sleep hygiene behavior in adults living with HIV/AIDS: a randomized control pilot stud of the SystemCHANGE-HIV intervention. Appl Nurs Res. 2013;26:95–91. doi: 10.1016/j.apnr.2012.10.002.
    1. SystemCHANGE: Results of a lifestyle exercise intervention trial. Ann Behav Med; 2012;4(3). doi:10.4172/2155-6113.1000200.
    1. Moore SM, Charvat J, Andrisin S, et al. SystemCHANGE: Improving exercise by increasing family social support. Ann Behav Med. 2010;39:S154.
    1. Alemi F, Baghi H. Self-experiments and analytical relapse prevention. Qual Manag Health Care. 2008;17(1):53–65. doi: 10.1097/01.QMH.0000308638.04850.48.
    1. Alemi F, Neuhauser D, Ardito S, et al. Continuous self-improvement: systems thinking in a personal context. Jt Comm J Qual Improv. 2000;26(2):74–86.
    1. Russell CL, Conn VS, Ashbaugh C, et al. Taking Immunosuppressive Medications Effectively (TIMELink): A pilot randomized controlled trial in adult kidney transplant recipients. Clin Transplant. 2010;25(6):864–70. doi: 10.1111/j.1399-0012.2010.01358.x.
    1. Conn VS, Hafdahl AR, Cooper P, et al. Interventions to improve medication adherence among older adults: Meta-analysis of adherence outcomes among randomized controlled trials. The Gerontologist. 2009;49:447–62. doi: 10.1093/geront/gnp037.
    1. Molloy GJ, O'Carroll RE, Witham MD, McMurdo MET. (2011) Interventions to enhance adherence to medications in patients with heart failure, Circulation: Heart Failure. 2012; 5: 126–33.
    1. Christensen A, Osterberg LG, Hansen EH. Electronic monitoring of patient adherence to oral antihypertensive medical treatment: a systematic review. J Hypertens. 2009;27(8):1540–51. doi: 10.1097/HJH.0b013e32832d50ef.
    1. Kripalani S, Yao X, Haynes RB. Interventions to enhance medication adherence in chronic medical conditions: a systematic review. Arch Intern Med. 2007;167(6):540–50. doi: 10.1001/archinte.167.6.540.
    1. McDonald HP, Garg AX, Haynes RB. Interventions to enhance patient adherence to medication prescriptions. JAMA. 2002;288(22):2868–79. doi: 10.1001/jama.288.22.2868.
    1. Conn VS, Ruppar TM, Enriquez M, et al. Medication adherence interventions that target subjects with adherence problems: Systematic review and meta-analysis. Research in social & administrative pharmacy : RSAP. 2015.
    1. Conn VS, Ruppar TM, Chan KC, et al. Packaging interventions to increase medication adherence: systematic review and meta-analysis. Curr Med Res Opin. 2015;31(1):145–60. doi: 10.1185/03007995.2014.978939.
    1. Chisholm MA, Mulloy LL, Jagadeesan M, et al. Impact of clinical pharmacy services on renal transplant patients’ compliance with immunosuppressive medications. Clin Transplant. 2001;15(5):330–6. doi: 10.1034/j.1399-0012.2001.150505.x.
    1. Hardstaff R, Green K, Talbot D. Measurement of compliance posttransplantation--the results of a 12-month study using electronic monitoring. Transplant Proc. 2003;35(2):796–7. doi: 10.1016/S0041-1345(03)00074-5.
    1. Chisholm-Burns MA, Spivey CA, Graff ZJ, Lee JK, Sredzinski E, Tolley EA. Improving outcomes of renal transplant recipients with behavioral adherence contracts: a randomized controlled trial. Am J Transplant. 2013;9:2364–2373.
    1. Klein A, Kramer I, Otto G. Impact of a pharmaceutical care program on liver transplanted patients’ compliance with immunosuppressive medication-a prospective, randomized, controlled trial using electronic monitoring. Am J Transplant. 2006;6(2):212.
    1. Chisholm MA, Vollenweider LJ, Mulloy LL, et al. Renal transplant patient compliance with free immunosuppressive medications. Transplantation. 2000;70(8):1240–44. doi: 10.1097/00007890-200010270-00020.
    1. Russell CL, Conn VS, Ashbaugh C, et al. Medication adherence patterns in adult renal transplant recipients. Res Nurs Health. 2006;29(6):521–32. doi: 10.1002/nur.20149.
    1. Frazier PA, Davis-Ali SH, Dahl KE. Correlates of noncompliance among renal transplant recipients. Clin Transpl. 1994;8(6):550–57.
    1. Bronfenbrenner U. (1994). Ecological models of human devleopment. In International Encyclopedia of Education. Vol 3. 2nd Ed. Pxford: Elsevier.
    1. Sketris I, Waite N, Grobler K, et al. Factors affecting compliance with cyclosporine in adult renal transplant patients. Transplant Proc. 1994;26(5):2538–41.
    1. Dunn TB, Browne BJ, Gillingham KJ, et al. Selective retransplant after graft loss to lonadherence: success with a second chance. Am J Transplant. 2009;9(6):1337–46. doi: 10.1111/j.1600-6143.2009.02625.x.
    1. Russell CL, Kilburn E, Conn VS, et al. Medication taking beliefs of adult renal transplant recipients. Clin Nurse Spec. 2003;17(4):200–08. doi: 10.1097/00002800-200307000-00018.
    1. Ruppar T, Russell CL. Medication-taking behavior in successful renalt transplants. Prog Transplant. 2009;19(2):167–72. doi: 10.7182/prtr.19.2.2652p03x0vvx7665.
    1. Messina CJ, Russell CL, Ewigman A, et al. Teaching patients about kidney transplantation: documentation. Prog Transplant. 2000;10(3):169–76. doi: 10.7182/prtr.10.3.5858356751630720.
    1. Matteson MM, Russell CL. Systematic review of continuous self-improvement interventions. Clinical Nursing Studies. 2013;1(1):10–25. doi: 10.5430/cns.v1n1p10.
    1. Ojogho ON, Ben-Youssef R, Chen LJ, et al. Simultaneous pediatric kidney transplantation and ureterocystoplasty in a 20-month-old boy. Pediatr Transplant. 2007;11(4):436–40. doi: 10.1111/j.1399-3046.2007.00696.x.
    1. Russell CL, Conn VS, Ashbaugh C, et al. Preliminary data: predictors of medication non-adherence in adult renal transplant recipients. 2007.
    1. Dunbar-Jacob J, Sereika SM, Foley SM, et al. Adherence to oral therapies in pelvic inflammatory disease. J Women’s Health. 2004;13(3):285–91. doi: 10.1089/154099904323016446.
    1. Russell CL, Conn V, Ashbaugh C, et al. Intra-subject medication adherence patterns. Clin Nurs Res. 2007;16:153–63. doi: 10.1177/1054773806296429.
    1. Quinn TC, Wawer MJ, Sweankambo N, et al. Viral load and heterosexual transmission of human immunodeficiency virus type 1. Rakai Project Study Group. N Engl J Med. 2000;342:921–29. doi: 10.1056/NEJM200003303421303.
    1. Moore RD. Cost Effectiveness of Combination HIV Therapy. Pharmacoeconomics. 2000;4:325–30. doi: 10.2165/00019053-200017040-00002.
    1. Fallab-Stubi XL, Sellweger JP, Sauty A, et al. Electronic monitoring of adherence to treatment in the preventivie chemotherapy of tuberculosis. Int J Tuberc Lung Dis. 1998;2:525–30.
    1. Denhaerynck K, Schaefer-Keller P, Young J, et al. Examining assumptions regarding valid electronic monitoring of medication therapy: development of a validation framework and its application on a European sample of kidney transplant patients. BMC Med Res Methodol. 2008;8:5. doi: 10.1186/1471-2288-8-5.
    1. Bowling A. Just one question: If one question works, why ask several? J Epidemiol Community Health. 2005;59(5):342–45. doi: 10.1136/jech.2004.021204.
    1. Vaux A, et al. The social support appraisals (SS-A) scale: Studies of reliability and validity. Am J Community Psychol. 1986;14(2):195–219. doi: 10.1007/BF00911821.
    1. Russell CL, Ashbaugh C, Peace L, et al. Time-in-a-Bottle (TIAB) study: Patterns, predictors, and outcomes of medication adherence in adult kidney transplant recipients. Clin Transplant. 2013;27:E580–E90. doi: 10.1111/ctr.12203.
    1. Dolansky M,. MS. Systems Thinking: Advancing the Science of Continuous Quality Improvement. Secondary Systems Thinking: Advancing the Science of Continuous Quality Improvement. . Accessed 15 May 2015.
    1. Dolansky M, Moore S. Quality and Safety Education for Nurses (QSEN): The Key is Systems Thinking. Online J Issues Nurs. 2013;18:1–6.
    1. Russell CL, Conn V, Ashbaugh C, et al. Taking immunosuppressive medications effectively (TIMELink): A pilot randomized controlled trial in adult kidney transplant recipients. Clin Transpl. 2011;25(6):864–70. doi: 10.1111/j.1399-0012.2010.01358.x.
    1. Russell CL, Cetingok M, Hamburger KQ, et al. Medication adherence in older renal transplant recipients. Clin Nurs Res. 2010;19(2):95–112. doi: 10.1177/1054773810362039.
    1. Frazier PA, Tix AP, Barron KETMaMEiCPR Testing moderator and mediator effects in counseling psychology research. J Couns Psychol. 2004;51(1):115–34. doi: 10.1037/0022-0167.51.1.115.
    1. Sobel ME. Asymptotic intervals for indirect effects in structural equations models. In: Leinhart S, editor. Sociological methodology. San Francisco: Jossey-Bass; 1982. pp. 290–312.
    1. Haynes RB, Yao X, Degani A, et al. Interventions for enhancing medication adherence [Systematic Review] Cochrane Database Syst Rev. 2005;4:CD000011.
    1. Russell CL, Ruppar TM, Matteson M. Improving medication adherence: moving from intention and motivation to a personal systems approach. Nurs Clin North Am. 2011;46(3):271–81. doi: 10.1016/j.cnur.2011.05.004.
    1. Deming E, Orsini JN. The Essential Deming: Leadership Principles from the Father of Quality. New York, NY: McGraw-Hill Education. 2012.
    1. Proposed Healthy People 2020 objectives. Secondary Proposed Healthy People 2020 objectives 2010. .

Source: PubMed

Спонсоры и соавторы

Заболевания

Медикаментозные вмешательства

Подписаться